The DUTCH Test: What It Measures and What It Can't

You have a twenty-page PDF in front of you, several values flagged in red, and a practitioner already recommending DIM, an adaptogen, and progesterone cream. The DUTCH test produces genuinely useful data — some of it unavailable on a standard serum panel. But a pattern on the report is a starting point, not a verdict. Before anyone builds a protocol off the flags, it’s worth knowing what the test actually measures and what it can’t.

What the DUTCH Test Actually Measures

DUTCH stands for Dried Urine Test for Comprehensive Hormones. You collect urine on filter paper at four points across a day, and the lab measures hormone metabolites: the breakdown products your body excretes after it has used a hormone.

That metabolite focus is the whole design. The panel captures several things at once:

Estrogen and its metabolites — estrone, estradiol, estriol, and the Phase I and Phase II pathway products (2-OH, 4-OH, 16-OH, and their methylated forms). This is where the 2:16 ratio and methylation efficiency live.
Progesterone metabolites — primarily pregnanediol (PDG), reflecting progesterone exposure over the collection window.
Androgens — testosterone, DHEA-S, and downstream markers like androsterone and etiocholanolone.
Cortisol and cortisone — both total output and the diurnal pattern, captured by the four-point collection.
Melatonin and, on DUTCH Plus, organic acid markers for B-vitamin and neurotransmitter metabolism.

What this means:

The estrogen metabolism pathway — how your body processes estrogen through Phase I and Phase II — is data a standard serum panel doesn’t give you.
The four-point cortisol rhythm shows the shape of your HPA axis across the day, which a single morning blood draw cannot.

What the DUTCH Test Doesn’t Tell You

If the test measures what you excrete, the limits follow from that. Dried urine reflects metabolite excretion, not circulating hormone; it doesn’t tell you how much active hormone is in your bloodstream right now, or, more importantly, how your cells are responding to it. Receptor sensitivity and tissue-level effects don’t show up in urine.

That gap matters most where the report looks most authoritative. An elevated estrogen metabolite is not a diagnosis of “estrogen dominance,” and it doesn’t automatically call for DIM; your menstrual status, your phase of perimenopause, and your actual symptoms change what the number signifies. The same is true of cortisol: a flat diurnal pattern in chronic threat physiology and a flat pattern in a different terrain are the same data point pointing at two different problems. The number doesn’t interpret itself.

And it doesn’t tell you the result would read the same next month. The DUTCH captures the output of a system in whatever autonomic state it sat in during collection, and that state reaches past cortisol. Chronic stress measurably shifts CYP enzyme activity, and the CYP pathway builds the estrogen metabolites the panel reports: the 2-OH, 4-OH, and their methylated forms. Add the shared methylation machinery — COMT and its methyl donors clear both stress catecholamines and catechol estrogens — and a stretch of threat physiology can surface as “estrogen dominance” or “sluggish methylation,” a state being read as a fixed hormone problem. Run the same woman in a regulated month and the pattern reads differently, with her ovaries doing nothing different.

Common misinterpretations:

A flagged metabolite equals a diagnosis (it flags a question for investigation, not an answer).
“Estrogen dominance” on the report means you need DIM (the recommendation has to account for your phase, symptoms, and detox pathway, not just the flag).
A flat or low cortisol pattern means “adrenal fatigue” (the same pattern can reflect HPA dysregulation, threat physiology, or a sleep problem; the driver determines the response).

There’s a structural reason this gets misread. The lab only opens ordering accounts to providers legally able to order labs, so the test is gated behind a license. But the gate has a side door: through authorization-network platforms (e.g., Rupa or Fullscript, and other similar lab platforms), an unlicensed coach can recommend the panel, have a licensed clinician they’ve never met authorize the order, and then interpret the twenty-page result with the client. The person who signed for the test and the person reading it to you aren’t always the same. A license to order labs is not training in how to read one. DUTCH onboards its own providers with a multi-part course precisely because ordering authority doesn’t confer interpretive skill. Reading the panel well takes an understanding of steroidogenesis, HPA–HPG axis interactions, and Phase I and Phase II detoxification in a perimenopausal context. Without it, interpretation collapses into pattern-matching the flags: DIM for the estrogen metabolites, an adaptogen for the cortisol curve, progesterone cream for low PDG (which can itself be a downstream readout of HPA load, not a primary deficiency), treating the outputs, never the generator, and missing the cases that need medical management rather than a supplement.

The Better Question to Ask

If the report can’t interpret itself, the question shifts away from the result and onto the interpretation.

Instead of asking: “What do my DUTCH results mean?”

Ask: “Who’s interpreting this, and against what — my symptom timeline and menstrual status, or just the reference ranges? Is that the same person who ordered it, and are they trained to read it — or only licensed to order it?”

What this question reveals:

Whether your practitioner is reading the estrogen metabolism pathway and the cortisol rhythm in clinical context, or treating the flags.
Whether the proposed protocol targets the mechanism generating the pattern or just the downstream value.

What to Do With This

Where you go next depends on what’s flagged.

If estrogen metabolites are flagged:

Ask how the 2:16 ratio and methylation efficiency were read against your cycle or menopausal status, not the range alone.
Ask what the recommendation actually targets: Phase I production, Phase II clearance, or methylation capacity. “Take DIM” without that distinction is a flag-level answer.

If the cortisol pattern is dysregulated:

Ask what’s driving the rhythm: sleep, threat physiology, training load, or HPA axis dysregulation. An adaptogen on top of an unaddressed driver doesn’t move the generator.
A four-point curve is genuinely useful data. Make sure it’s read as a question about terrain, not a label.

Red flags — when to push back:

A protocol built entirely off the red-flagged values, with no reference to your symptom timeline or menstrual status.
“Estrogen dominance” or “adrenal fatigue” offered as a diagnosis from the panel alone.
Findings that suggest significant hormonal or HPA dysregulation that no licensed clinician has reviewed.

DUTCH Test: Common Questions

What is the DUTCH test? The DUTCH test is a dried urine panel that measures hormone metabolites: estrogen and its Phase I/II breakdown products, progesterone and androgen metabolites, and a four-point cortisol rhythm. It captures how your body processes hormones over a collection window, which is information a standard serum draw doesn’t provide.

Are DUTCH test results a diagnosis? No. The panel flags patterns for investigation; it doesn’t diagnose conditions. Dried urine reflects what you excrete, not circulating hormone levels or how your cells respond, and it can’t diagnose perimenopause — that’s a clinical determination based on symptoms and serum markers in context.

What should I do if my DUTCH test results are abnormal? Before acting on the flags, confirm your results were read against your symptom timeline and menstrual status, not just the reference ranges, and ask whether the recommended protocol addresses what’s driving the pattern or only the flagged value. Findings that suggest significant imbalance warrant review by a licensed clinician.

TL;DR

The DUTCH test measures hormone metabolites in dried urine — what you excrete, not the circulating hormone in your blood or how your cells respond to it.
It does some things serum can’t: the estrogen metabolism pathway and the four-point cortisol rhythm.
A flagged value is a question, not a diagnosis. “Estrogen dominance” and “adrenal fatigue” are not conclusions the panel can deliver on its own.
The result partly reflects the state your system was in during collection — threat physiology can move the pattern on its own, so it isn’t a fixed snapshot.
Better question: who’s interpreting this, against what — your symptom timeline and menstrual status, or just the reference ranges?

A twenty-page report is not an answer. The DUTCH gives you a detailed snapshot of your hormonal terrain, and like any terrain map it only means something once someone reads it against where you actually are. Get the context. Ask who’s interpreting it. Then decide what the pattern is asking.

If you’re holding a DUTCH report nobody has read against your actual symptoms, a Vital Signal Check is where that conversation starts. Forty-five minutes, in person in Sandpoint or via Zoom, to decode what the panel is reporting and find the next useful question.

Estrogen Dump vs. Estrogen Deficiency — The estrogen metabolites the DUTCH flags are this clearance story: in perimenopause the problem is usually turbulence and sluggish clearance, not a number on a panel. Read this before you read “high estrogen metabolites” as “estrogen dominance.”
Doing Everything Right and Nothing Is Working — The four-point cortisol rhythm the DUTCH measures is central to this pattern. What a dysregulated HPA axis is actually doing, and why an adaptogen on top of it doesn’t move the generator.